Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Respiration; International Review of Thoracic Diseases|January 1, 1995
Nebulizer performance: AFLM study. Association Française de Lutte contre la MucoviscidoseF Faurisson, J F Dessanges, A Grimfeld, et al.
The Journal of Antimicrobial Chemotherapy|August 23, 2008
HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitroB Roquebert, F Damond, G Collin, et al.
Clinical and Experimental Dermatology|April 12, 2017
Extensive levamisole-induced vasculitisC Desvignes, C Becquart, D Launay, et al.
HIV Medicine|July 9, 2004
Determination of indinavir and nelfinavir trough plasma concentration efficacy thresholds according to virological response in HIV-infected patientsX Duval, G Peytavin, I Albert, et al.
Revue Des Maladies Respiratoires|January 1, 1996
[Comparative study of the performance and ergonomics of nebulizers in cystic fibrosis]F Faurisson, J F Dessanges, A Grimfeld, et al.
Medecine Et Maladies Infectieuses|November 15, 2019
Management of oral antiretroviral administration in patients with swallowing disorders or with an enteral feeding tubeCarine San, M P Lê, S Matheron, et al.
Infectious Diseases Now|September 23, 2024
A case series of intermittent nucleoside analogue-based (NA) regimen to maintain HBV virological suppression in coinfected HBV/HIV patients with suppressed viremiaS Seang, P Detruchis, E Todesco, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinumG Mathé, Y Kidani, M Segiguchi, et al.
The British Journal of Dermatology|May 14, 2016
Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi sarcoma skin lesionsA Desnoyer, N Dupin, L Assoumou, et al.
AIDS (London, England)|August 17, 1999
Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapyC Piketty, E Race, P Castiel, et al.
Pageof 8